Cardiovascular risk factors in relatives of type 2 diabetics with normal glucose tolerance test and elevated one-hour plasma glucose

Endokrynologia Polska

Volumn 61, Issue 4, 2010, Pages 359-363

  Taheri, Nader ^a   Iraj, Bijan ^a   Amini, Massoud ^a   Amini, Payvand ^a   Aminorroaya, Ashraf ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Glucose tolerance test; Risk factors; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; ETHNICITY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RELATIVE; WAIST CIRCUMFERENCE;

ADULT; AREA UNDER CURVE; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 77957276720     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-1431.
2. Abdul-Ghani MA, DeFronzo RA. Plasma glucose concentration and prediction of future risk of type 2 diabetes. Diabetes Care 2009; 32 (Suppl. 2): S194-S198.
3. Tuomilehto J, Lindstrom J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350. (Pubitemid 32378388)
4. Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403. (Pubitemid 34437694)
5. Gerstein HC, Yusuf S, Bosch J et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 2006; 368: 1096-1105.
6. Succurro E, Marini MA, Arturi F et al. Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. Atherosclerosis 2009; 207: 245-249.
7. Unwin N, Shaw J, Zimmet P et al. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002; 19: 708-723.
8. Abdul-Ghani MA, Williams K, DeFronzo RA et al. What is the best predictor of future type 2 diabetes? Diabetes Care 2007; 30: 1544-1548.
9. Abdul-Ghani MA, Abdul-Ghani T, Ali N et al. One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care 2008; 31: 1650-1655.
10. Abdul-Ghani MA, Lyssenko V, Tuomi T et al. Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study. Diabetes Care 2009; 32: 281-286.
11. Bianchi C, Bonadonna R, Penno G et al. Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance and impaired beta cell function, insulin-resistance and worse cardiovascular risk profile. XXIII National Congress of the Italian Society for the study of Atherosclerosis (SISA), Italy, Nov 25-28 2009.
12. Vaccaro O, Riccardi G. Changing the definition of impaired fasting glucose: impact on the classification of individuals and risk definition. Diabetes Care 2005; 28: 1786-1788.
13. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 2002; 106: 3143-3421.
14. Harada N, Fukushima M, Toyoda K et al. Factors responsible for elevation of 1-h postchallenge plasma glucose levels in Japanese men. Diabetes Res Clin Pract 2008; 81: 284-289.
15. Meisinger C, Wolke G, Brasche S et al. Postload plasma glucose and 30-year mortality among nondiabetic middle-aged men from the general population: the ERFORT Study. Ann Epidemiol 2006; 16: 534-539.
16. Orencia AJ, Daviglus ML, Dyer AR et al. One-hour postload plasma glucose and risks of fatal coronary heart disease and stroke among nondiabetic men and women: the Chicago Heart Association Detection Project in Industry (CHA) Study. J Clin Epidemiol 1997; 50: 1369-1376.
17. Bardini G, Dicembrini I, Cresci B et al. Inflammation markers and metabolic characteristics of subjects with 1-h plasma glucose levels. Diabetes Care 2010; 33: 411-413.